Seelos Therapeutics, Inc.
(NASDAQ : SEEL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.32%198.241.3%$525.29m
GILDGilead Sciences, Inc.
1.40%66.880.9%$355.41m
ALXNAlexion Pharmaceuticals, Inc.
0.92%106.642.0%$330.79m
ILMNIllumina, Inc.
0.65%307.183.5%$317.97m
BIIBBiogen Inc.
2.59%241.731.3%$314.00m
CELGCelgene Corporation
0.40%99.351.3%$295.75m
VRTXVertex Pharmaceuticals Incorporated
1.86%179.411.9%$177.99m
AAgilent Technologies, Inc.
0.65%78.581.6%$177.01m
REGNRegeneron Pharmaceuticals, Inc.
3.37%295.782.6%$171.98m
SRPTSarepta Therapeutics, Inc.
-2.33%83.3714.6%$141.86m
EXASExact Sciences Corporation
-0.40%102.9924.1%$138.20m
ACADACADIA Pharmaceuticals Inc.
-1.13%41.2113.9%$124.03m
INCYIncyte Corporation
2.48%80.062.5%$87.32m
ALDRAlder Biopharmaceuticals, Inc.
0.11%18.6810.2%$76.49m
BMRNBioMarin Pharmaceutical Inc.
-0.28%75.794.3%$75.41m

Company Profile

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system disorders. Its portfolio include late-stage clinical assets targeting psychiatric and movement disorders. The company is headquartered in New York, NY.